cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Jaya Pramana
Contact Email
jayapram@gmail.com
Phone
-
Journal Mail Official
support@majalahpatologiindonesia.com
Editorial Address
Departemen Patologi Anatomik, Fakultas Kedokteran Universitas Indonesia Jl. Salemba Raya 6, Tromol Pos 3225, Jakarta 10002
Location
Unknown,
Unknown
INDONESIA
Majalah Patologi Indonesia
Published by Perhimpunan Ahli Patologi Indonesia
ISSN : 02157284     EISSN : 25279106     DOI : https://doi.org/10.55816/
Core Subject : Health,
Health Professions Public Health
Majalah Patologi Indonesia (MPI) digunakan sebagai wahana publikasi hasil penelitian, tinjauan pustaka, laporan kasus dan ulasan berbagai aspek di bidang patologi manusia. Tujuannya ialah menghadirkan forum bagi permakluman dan pemahaman aneka proses patologik serta evaluasi berbagai penerapan cara diagnostik sejalan dengan kemajuan perkembangan ilmu dan teknologi. Selain itu juga untuk merangsang publikasi barbagai informasi baru/mutakhir.
Arjuna Subject : Kedokteran - Patologi dan Kedokteran Kesehatan
Articles 392 Documents
 36   37   38   39   40 
Profil tumor neuroendokrin berdasarkan pengalaman lima tahun di rumah sakit rujukan tersier di Palembang Sandria; Murti, Krisna
Majalah Patologi Indonesia Vol. 35 No. 1 (2026): MPI
Publisher : Perhimpunan Dokter Spesialis Patologi Anatomik Indonesia (PDSPA)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55816/mpi.v35i1.664

Abstract

Background Neuroendocrine tumors (NET) are a type of uncommon neoplasms originating from the neuroendocrine cell system. Recent decades, the prevalence of NET gradually increases, attributing partially to the utilization of advanced detection procedures using modern methodologies. Objective The aim of this research was to assess the profile of neuroendocrine tumors of 5 years experiences in our hospital. Methods In this retrospective cross-sectional study, a thorough examination was performed on a total of 71 cases obtained from archives of the Department of Anatomic Pathology Mohammad Hoesin Hospital, over the period from 2017 to 2021. The Chi-square test was used for data analysis. Bivariate analysis was performed using binary logistic regression tests to investigate the correlation between the independent variables, including gender and tumor site, and the dependent variables. Result and Discussion Out of the 71 recorded samples, 69 samples were subjected to be analyzed while the remaining samples were excluded due to have incomplete data. Four different antibodies were evaluated to find the association between these antibodies and tumor with location (chromogranin, P=0.792; synaptophysin, P=0.100; Ki-67, P=0.026; CD56, P=0.511) and gender (chromogranin, P=0.627; synaptophysin, P=0.929; Ki-67, P=0.315; CD56, P=0.524). Conclusion: The study showed synaptophysin has the highest positive rate on NET diagnosis. There is no association was found between chromogranin, synaptophysin, and CD56 staining to tumor location, except for Ki-67. Similarly, no association was found between staining performance (chromogranin, synaptophysin, Ki-67, CD56) with gender.
Relationship of the Number of Black Dots in the Nuclei of Argyrophilic Nucleolar Organizing Regions (AgNORs) Expressed Epithelial Cells with Nottingham Grading System in Invasive Breast Carcinoma of No Special Type (IBC-NST) Basrul, Mohd. Yuwanda; Delyuzar, Delyuzar; Intan, T. Kemala; Soekimin, Soekimin; Alferraly, T. Ibnu
Majalah Patologi Indonesia Vol. 35 No. 1 (2026): MPI
Publisher : Perhimpunan Dokter Spesialis Patologi Anatomik Indonesia (PDSPA)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55816/mpi.v35i1.669

Abstract

Background Breast cancer is a malignant disease in women. The high number of breast cancer cases is caused by multiple factors, including barriers to early detection of breast cancer, socio-economic and geographical factors, and the difficulty of affordable, timely and effective health services. IBC-NST has the highest incidence among breast cancer cases with a 10 year survival rate (65-78%). AgNORs parameters have been shown to represent a reliable tool for determining the clinical outcome of cancer diseases, being an independent prognostic factor in many types of tumors.   Method Descriptive analytics research was carried out on slides from 31 patients with IBC-NST. Each slide was stained with H&E stainning to assess the Nottingham grading system and stained with AgNORs to assess the number of black dots in epithelial cell nuclei that expressed AgNORs. All clinicopathological data were taken from medical records/pathology archives. Logistic regression test (p<0.005) was used to assess the relationship between the number of black dots in epithelial cell nuclei expressing AgNORs and the Nottingham grading system in IBC-NST.   Results The highest cases were in the age group ≤40-50 years (range: 50.1 years), the highest grading was in grade 3 of the Nottingham grading system (48.8%), the lowest number of black dots was 576 dots and the highest was 1,036 dots (mean 798.80, median 710.0 and standard deviation 144.71) and the highest number of black dots was in grade 3 of the Nottingham grading system.   Conclusion Assessment of the number of black dots in the nuclei of epithelial cells expressing AgNORs associated with Nottingham grading system can be used as an indication of prognosis in patients with IBC-NST.

Page 40 of 40 | Total Record : 392

 36   37   38   39   40 

Filter by Year

2010 2026


Reset
Filter By Issues
All Issue Vol. 35 No. 1 (2026): MPI Vol. 34 No. 3, September 2025 Vol. 34 No. 2, Mei 2025 Vol. 34 No. 1, Januari 2025 Vol. 33 No. 3, September 2024 Vol. 33 No. 2, Mei 2024 Vol. 33 No. 1, Januari 2024 Vol. 32 No. 3, September 2023 Vol. 32 No. 2, Mei 2023 Vol. 32 No. 1, Januari 2023 Vol 31. No. 3, September 2022 Vol. 31 No. 2, Mei 2022 Vol 31 No 2 (2022): MPI Vol. 31 No. 1, Januari 2022 Vol 31 No 1 (2022): MPI Vol 30 No 3 (2021): MPI Vol. 30 No. 3, September 2021 Vol 30 No 2 (2021): MPI Vol. 30 No. 1 (2021): MPI Vol 30 No 1 (2021): MPI Vol 29 No 3 (2020): MPI Vol 29 No 2 (2020): MPI Vol. 29 No. 1 (2020): MPI Vol 29 No 1 (2020): MPI Vol 28 No 3 (2019): MPI Vol 28 No 2 (2019): MPI Vol 28 No 1 (2019): MPI Vol 27 No 3 (2018): MPI Vol 27 No 2 (2018): MPI Vol 27 No 1 (2018): MPI Vol 26 No 3 (2017): MPI Vol 26 No 2 (2017): MPI Vol 24 No 3 (2015): MPI Vol 24 No 2 (2015): MPI Vol 26 No 1 (2017): MPI Vol 25 No 2 (2016): MPI Vol 25 No 3 (2016): MPI Vol 25 No 1 (2016): MPI Vol 23 No 2 (2014): MPI Vol 24 No 1 (2015): MPI Vol 23 No 3 (2014): MPI Vol 23 No 1 (2014): MPI Vol 21 No 3 (2012): MPI Vol 21 No 2 (2012): MPI Vol 21 No 1 (2012): MPI Vol 20 No 3 (2011): MPI Vol 20 No 2 (2011): MPI Vol 20 No 1 (2011): MPI Vol 22 No 3 (2013): MPI Vol 22 No 2 (2013): MPI Vol 22 No 1 (2013): MPI Vol 19 No 2 (2010): MPI Vol 19 No 1 (2010): MPI More Issue